RxDoctor Payments Data

Todd Kazdan, DO

Family Medicine · Davie, FLNPI 1376592048

Payments from drug & device makers

$533in general payments, 2019–2025

Across 26 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$118
  • Verity Pharmaceuticals Inc.$76
  • Lilly USA, LLC$68
  • Amgen$65
  • Edwards Lifesciences$55
  • Phathom Pharmaceuticals, Inc.$41
  • plus $110 from 6 others

What the payments were for

  • Food & beverage$533100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$533 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$231,465
Medicare patients
484
Services billed
3,604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide129$137,665
JardianceEmpagliflozin124$129,116
EliquisApixaban71$84,270
MounjaroTirzepatide75$79,302
JanuviaSitagliptin Phosphate45$54,419
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$53,254
JanumetSitagliptin Phos/Metformin Hcl27$28,759
Tresiba Flextouch U-200Insulin Degludec34$27,703
Synjardy XrEmpagliflozin/Metformin Hcl28$26,701
XareltoRivaroxaban17$25,150
FarxigaDapagliflozin Propanediol26$21,778
Janumet XrSitagliptin Phos/Metformin Hcl20$20,442
Tresiba Flextouch U-100Insulin Degludec28$18,002
TrulicityDulaglutide12$15,507
Lantus SolostarInsulin Glargine,hum.Rec.Anlog71$15,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$118$137,665129 claims
Lilly USA, LLCMounjaro, Trulicity$68$94,80887 claims
GSKTrelegy Ellipta, Breo Ellipta$14$64,10788 claims
AbbVieSynthroid$16$8,57892 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Davie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →